Avestar Capital, LLC Gilead Sciences, Inc. Transaction History

Avestar Capital, LLC

$951 Million
Q3 2024

A detailed history of Avestar Capital, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Avestar Capital, LLC holds 6,935 shares of GILD stock, worth $623,317. This represents 0.06% of its overall portfolio holdings.

Number of Shares

6,935

Previous 5,401 28.4%

Holding current value

$623,317

Previous $370,000 57.03%

% of portfolio

0.06%

Previous 0.04%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$66.59 - $83.99 $102,149 - $128,840	1,534 Added 28.4%	6,935 $581,000
Q2 2024 Aug 08, 2024	BUY	$63.15 - $72.88 $35,869 - $41,395	568 Added 11.75%	5,401 $370,000
Q1 2024 May 10, 2024	SELL	$71.58 - $87.29 $16,821 - $20,513	-235 Reduced 4.64%	4,833 $354,000
Q4 2023 Feb 12, 2024	BUY	$73.27 - $83.09 $93,345 - $105,856	1,274 Added 33.58%	5,068 $410,000
Q3 2023 Oct 20, 2023	BUY	$73.94 - $80.67 $51,314 - $55,984	694 Added 22.39%	3,794 $284,000
Q2 2023 Aug 01, 2023	BUY	$76.01 - $86.7 $45,301 - $51,673	596 Added 23.8%	3,100 $238,000
Q1 2023 Apr 20, 2023	SELL	$77.31 - $88.08 $12,988 - $14,797	-168 Reduced 6.29%	2,504 $207,000
Q4 2022 Jan 20, 2023	BUY	$62.32 - $89.47 $166,519 - $239,063	2,672 New	2,672 $0
Q2 2021 Aug 03, 2021	SELL	$63.47 - $69.35 $220,367 - $240,783	-3,472 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$60.0 - $68.46 $208,320 - $237,693	3,472 New	3,472 $224,000
Q3 2020 Oct 29, 2020	SELL	$62.1 - $78.08 $290,441 - $365,180	-4,677 Closed	0 $0
Q2 2020 Jul 29, 2020	SELL	$72.34 - $84.0 $540,813 - $627,984	-7,476 Reduced 61.52%	4,677 $360,000
Q1 2020 May 12, 2020	BUY	$62.63 - $80.22 $22,233 - $28,478	355 Added 3.01%	12,153 $909,000
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $20,026 - $22,028	-325 Reduced 2.68%	11,798 $766,000
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $14,127 - $15,594	226 Added 1.9%	12,123 $768,000
Q2 2019 Aug 06, 2019	BUY	$61.87 - $69.38 $309 - $346	5 Added 0.04%	11,897 $798,000
Q1 2019 May 09, 2019	BUY	$62.53 - $70.05 $1,625 - $1,821	26 Added 0.22%	11,892 $769,000
Q4 2018 Jan 25, 2019	SELL	$60.54 - $79.0 $121 - $158	-2 Reduced 0.02%	11,866 $739,000
Q3 2018 Oct 23, 2018	SELL	$71.28 - $78.92 $11,832 - $13,100	-166 Reduced 1.38%	11,868 $913,000
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $583 - $681	-9 Reduced 0.07%	12,034 $849,000
Q1 2018 May 10, 2018	BUY	$72.84 - $88.8 $3,714 - $4,528	51 Added 0.43%	12,043 $904,000
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $853,230 - $1 Million	11,992	11,992 $855,000

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avestar Capital, LLC with notifications on news.

Account

Avestar Capital, LLC Gilead Sciences, Inc. Transaction History